News
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting earnings this Monday after the bell. Here’s what to ...
Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) will be reporting earnings this Monday after market hours. Here’s what ...
Sage Therapeutics, Inc. (Nasdaq: SAGE), today reported business highlights and financial results for the second quarter ended June 30, 2025.
"This is a game changer for many who noticed a step change disease progression - some noticing improvement in function. Some ...
Twenty-one companies in the healthcare sector released their quarterly results in the week ending August 1. With this, over ...
The FDA has deemed Biogen's tofersen reasonably likely to produce a clinical benefit for patients.
Equities extended their July advance, with the S&P 500 set for its longest streak of monthly gains since September.
17h
Medpage Today on MSNQuestions Abound About Treating AMD, Geographic Atrophy at the Same TimeLONG BEACH, Calif. -- Concomitant treatment with drugs for geographic atrophy (GA) and neovascular macular degeneration (nAMD ...
16h
GB News on MSNNew motor neurone disease treatment approved for use in Britain in historic breakthroughA groundbreaking new treatment for motor neurone disease (MND) has been approved for use in the UK, offering fresh hope after decades of despair. But campaigners warn that patients may still have to ...
At 3:08 p.m. ET (20:08 GMT), the Dow Jones Industrial Average traded 120 points, or 0.3%, the S&P 500 index fell 0.01% after ...
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results